Mechanisms of Toxicity Flashcards

1
Q

What are the 4 major causes of toxicity?

A

ADME mediated
1. Disruption of ADME leads to poor metabolization and higher chemical concentrations in the body
2. The metabolization of non-toxic chemical leads to generation of a toxic chemical = Bioactivation

Pharmacodynamic mediated
3. The chemical disrupts the physiology of the cell via non-specific pathways (e.g. oxidative stress, apoptosis, necrosis etc)
4. The chemical interact specifically with biological targets, leading to specific target-mediated toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. What is ADME mediated toxicity?
A

When drugs/chemicals disrupt ADME processes - can disrupt one or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the major pharmacokinetic effects of ADME mediated toxicity?

A

Inhibition of metabolism
Induction of metabolism
Altered drug absorption
Displacement from plasma protein binding sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ADME mediated toxicity - effect on metabolism

A

CYP450s can be induced or inhibited by chemicals.
- reduced metabolization of a drug can lead to build up (higher than usual concentrations) increasing the risk of toxicological effects
- increased metabolization can result in lower than expected drug levels and reduced therapeutic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Example of ADME mediated toxicity - Statins + CYP3A4 inhibitors

A

Statins reduce LDL cholesterol in the blood. Help prevent heart disease and stroke.

High dose statin therapy can lead to rhabdomyolysis (results in death of muscle fibres - release toxins into the blood). Can lead to renal failure

Some statins are highly metabolised by CYP3A4. Inhibitors of CYP3A4 (eg. fibrates or calcium channel blockers) can increase the concentration of these statins.

When administered together, these drugs can:
- reduce the metabolism of statins
- increase the levels of statins in the blood
- increase risk of rhabdomyolysis

The use of non-CYP3A4-metabolised statins is preferred for patients taking other drugs that inhibit the CYP3A4 pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Example of ADME mediated toxicity - Omeprazol + Clopidogrel

A

Clopidogrel - antiplatelet medication - used to reduce risk of heart disease and stroke in those at high risk
It is a prodrug.

Omeprazole - protein pump inhibitor - used to treat gastroesophageal reflux disease, peptic ulcer disease and to prevent upper gastrointestinal bleeding.

Omeprazole is a CYP2C19 inhibitor - decreases the antiplatelet activity of clopidogrel by inhibiting the biotransformation of clopidogrel to its active metabolite.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Example of ADME mediated toxicity - St John’s Wort

A

St John’s Wort is a traditional medicine/herbal supplement - used to treat depressive and anxious states, nervousness, restlessness and sleep disorders

Issue - has a lot of drug interactions.

Drug interactions:
Significantly induces intestinal and hepatic CYP3A4
Moderately activates CYP2C19 and CYP2E1

Example: ethinyl-estradiol (hormonal contraception) -

St johns wart causes an induction of ethinyl estradiol metabolism via increased CYP3A activity. As the drug is being induced and metabolised very quickly - limited active effects of that drug - reduces efficacy of the oral contraceptive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ADME mediated toxicity - disruption of distribution

A

Two drugs may compete for the same binding sites - especially albumin binding sites

According to their affinity to the binding site, one drug may displace the other causing an increase in the free concentration of the displaced drug.
Results in increase of drug concentration at target site - may increase risk of developing adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Example of ADME mediated toxicity - disruption of distribution

A

Administration of aspirin to a patient treated chronically with warfarin results in displacement of the latter from its binding site.

The increase in plasma concentration of free warfarin causes serious hemorrhagic reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Bioactivation
A

The metabolization of non-toxic chemical leads to generation of a toxic chemical

so parent compound gets metabolised and produces a a compound that’s not the same as the parent compound (reactive metabolite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What metabolic systems are involved in bioactivation reactions?

A

CYPP450 and peroxidase enzyme - produce either electrophilic or radical metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Types of reactive metabolites

A

Electrophiles
Free radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Types of reactive metabolites - Electrophiles

A

Reactive metabolites are usually electrophiles (positive centre)
- typically either positively charged or have a partial positive charge

If not detoxified properly, electrophiles can reaction with nucleophiles (molecules containing negative centres), through covalent bond formation - form a new structure which may be toxic.

Electrophiles also react with proteins causing changes in protein structure - not recognised by the body - can look ‘foreign’ to the immune system leasing to an immune response

Can also react with nucleic acids on the DNA thereby causing changes to DNA structure or gene expression. Changes in DNA can lead to mutagenicity, teratogenicity or carcinogenicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of reactive metabolites - Free radicals

A

Free radicals - compounds that have unpaired electrons

Electrons need to be paired to form a chemical bond - a free radical cannot covalently bond with nucleophiles, instead they:

  • covalently bond with another free radical
  • take a hydrogen atom from a neutral molecule
  • take an electron to form an anion and generate a radical cation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Biological effects of reactive metabolites

A

If not detoxified, build up of reactive metabolites - leads to modification of biological macromolecules - build up of these molecules - leads to changes in DNA structure, proteins - leading to cell death via necrosis or apoptosis, carcinogenicity, hypersensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of reactive metabolites - Quinones

A

most frequent generated from free radicals
cause cytotoxicity, immunotoxicity, genotoxicity and carcinogenesis.

Can cause cell damage through alkylation of crucial cellular proteins and/or DNA.
Quinones are lead to formation of ROS
Production of ROS can cause severe oxidative stress within cells

17
Q

Example of drugs that produce quinones

A

Remoxipride - induces aplastic aneamia - taken off market

Paracetamol- produces quinones

18
Q

How does high does of paracetamol lead to severe liver toxicity?

A

At therapeutic levels in the blood, approximately 90% of paracetamol is broken down into non-toxic metabolites through sulfidation and glucuronidation pathways and then renally excreted.
- only small amount of the reactive intermediate (NAPQI) which is conjugated by GSH and excreted rendering it harmless.

However, at overdose levels, these pathways become saturated, resulting in large amounts of paracetamol being converted to NAPQI.
- not enough GSH to metabolise the drug - build of quinones - cause hepatic necrosis - can result in death

19
Q
  1. Non specific toxic responses
A

Chemicals can induce non-specific toxic responses - not mediated by drug interactions

Examples:
- Oxidative stress
- DNA damage
- Apoptosis
- Necrosis
- Immune or allergic response (drug hypersensitivity)

20
Q

Non specific toxic responses - Oxidative stress

A

Chemical/drugs can cause increase and build up of ROS - leading to oxidative stress - protein, lipid and nucleic acid modifications.

Changes in DNA can lead to mutagenicity, teratogenicity or carcinogenicity.

21
Q

Non specific toxic responses - drug hypersensitive reactions

A

Drug hypersensitivity reactions (DHR) include allergic, exaggerate, pharmacologic, and pseudo-allergic reactions to medications that result from an enhanced immunologic or inflammatory response.

Immune reactions: type 1-5

22
Q
  1. Target-mediated toxicity
A

Chemicals can interact with specific biological targets (e.g. receptors, enzymes, ion channels) which cause alteration of normal biological pathways leading to the disruption of the system.

23
Q

Target-mediated toxicity: drug development

A

Number of tests done - safety pharmacology panel - predicts whether new drugs can interact with targets that are known to be associated with serious adverse effects.

Classic example is hERG assay: drugs always screened with this assay

hERG = gene that effects potassium ion channel in the heart - required to regulate electrical activity of the heart. if the drug changes electrical activity - not carried forward

hERG inhibition can result in long QT syndrome - ventricular tachyarrythymia - potentially fatal disorder
- a number of drugs have the tendency to inhibit hERG

Makes hERG inhibition an important sagety target that must be avoided during drug development